Increased awareness, inadequate treatment, and poor control of cardiovascular risk factors in American young adults: 2005–2016

Abstract

Introduction There are little contemporary data about cardiovascular risk factors among young adults. We defined trends in diabetes mellitus (DM), hypertension, and hypercholesterolemia in American adults aged 18–44 years. Methods The National Health and Nutrition Examination Study serial cross-sectional surveys were used to define three time periods: 2005–2008, 2009–2012, and 2013–2016. Age-adjusted weighted trends of prevalence, awareness, treatment, and control of DM, hypertension, and hypercholesterolemia were calculated by linear regression modelling in the overall sample, males, and females. Trends were calculated after adjustment for age, race, body mass index, smoking status, education attainment, income, insurance status, and number of healthcare visits. Results From 2005–2008 to 2013–2016, 15,171 participants were identified. DM prevalence was stable ∼3%, hypertension prevalence was stable ∼11.0%, and hypercholesterolemia prevalence declined from 11.5% to 9.0% (ptrend = 0.02). DM awareness stayed stable between 61.1 and 74.1%, hypertension awareness increased from 68.7 to 77.7% (ptrend = 0.05), and hypercholesterolemia awareness was stable between 46.8 and 54.1%. DM and hypertension treatment improved markedly (ptrend < 0.001 and 0.05, respectively) but the hypercholesterolemia treatment was stable ∼30%. DM control improved across survey periods (7.7–17.4%, ptrend = 0.04) but hypertension control (∼50%) and hypercholesterolemia control (∼13%) remained stable. Prevalence, awareness, treatment, and control trends also differed between males and females. Conclusions There is a stable prevalence of DM, high and stable prevalence of hypertension, and declining prevalence of hypercholesterolemia among young Americans. Despite stable or increasing awareness of diabetes and hypertension, there are inadequate treatment and control trends for DM, hypertension, and hypercholesterolemia.

Association between serum uric acid and cardiovascular disease risk factors in adolescents in America: 2001-2018

“…Although traditional risk factor-based prediction models have significant values for most of the CVD events, they do not account for the entirety of cardiovascular risks [ 3 ]. The presence of residual risk has necessitated the evaluation of new risk factors to improve CVD risk stratification.…”

Prevalence of Diabetic Retinopathy in Undiagnosed Diabetic Patients: A Nationwide Population-Based Study

“…Considering that the duration of diabetes would be relatively short at a young age, factors other than HbA1c levels and duration of diabetes might contribute to the high prevalence of DR in patients with undiagnosed diabetes at a young age. This may be due to poor management of metabolic factors affecting DR other than glucose levels at younger ages [ 40 , 41 ]. Moreover, the stronger response to VEGF in younger ages, and decrease in growth hormone and insulin-like growth factor 1 in older ages could have contributed to the higher DR prevalence in younger ages [ 39 , 42 , 43 ].…”

Levels of TNF-α and Soluble TNF Receptors in Normal-Weight, Overweight and Obese Patients with Dilated Non-Ischemic Cardiomyopathy: Does Anti-TNF Therapy Still Have Potential to Be Used in Heart Failure Depending on BMI?

“…It is worth noting that patients in this group were least likely to receive statins with documented anti-inflammatory effects [ 63 ]. Obesity is a major risk factor for the development of heart failure [ 39 , 64 , 65 , 66 , 67 , 68 , 69 ]; therefore, it is worth considering which biomarkers should be used in obese patients. However, it is postulated that if patients already have heart failure, overweight and obese individuals are likely to have a surprisingly better prognosis compared to those with a normal body mass index [ 5 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 ].…”